261 related articles for article (PubMed ID: 34137463)
1. Activated Galectin-9/Tim3 promotes Treg and suppresses Th1 effector function in chronic lymphocytic leukemia.
Pang N; Alimu X; Chen R; Muhashi M; Ma J; Chen G; Zhao F; Wang L; Qu J; Ding J
FASEB J; 2021 Jul; 35(7):e21556. PubMed ID: 34137463
[TBL] [Abstract][Full Text] [Related]
2. [TIM-3/galectin-9 is involved in negative regulation of T cells in patients with chronic lymphocytic leukemia].
Xierenguli A; Zeng X; Pang N; Zhagn R; Ma J; Zhao Y; Qu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Nov; 36(11):1021-1025. PubMed ID: 33210597
[TBL] [Abstract][Full Text] [Related]
3. Modulatory effect of Tim-3/Galectin-9 axis on T-cell-mediated immunity in pulmonary tuberculosis.
Kang J; Wei ZF; Li MX; Wang JH
J Biosci; 2020; 45():. PubMed ID: 32345786
[TBL] [Abstract][Full Text] [Related]
4. The Tim-3/galectin-9 pathway involves in the homeostasis of hepatic Tregs in a mouse model of concanavalin A-induced hepatitis.
Ju Y; Shang X; Liu Z; Zhang J; Li Y; Shen Y; Liu Y; Liu C; Liu B; Xu L; Wang Y; Zhang B; Zou J
Mol Immunol; 2014 Mar; 58(1):85-91. PubMed ID: 24333756
[TBL] [Abstract][Full Text] [Related]
5. Galectin-9 alleviates acute graft-versus-host disease after haplo-hematopoietic stem cell transplantation by regulating regulatory T cell/effector T cell imbalance.
Pang N; Tudahong S; Zhu Y; He J; Han C; Chen G; Wang W; Wang J; Ding J
Immun Inflamm Dis; 2024 Feb; 12(2):e1177. PubMed ID: 38353382
[TBL] [Abstract][Full Text] [Related]
6. Activated Tim-3/Galectin-9 participated in the development of multiple myeloma by negatively regulating CD4 T cells.
Zhang R; Chen S; Luo T; Guo S; Qu J
Hematology; 2024 Dec; 29(1):2288481. PubMed ID: 38108336
[TBL] [Abstract][Full Text] [Related]
7. Expression of the Tim3-galectin-9 axis is altered in drug-induced maculopapular exanthema.
Fernandez-Santamaría R; Palomares F; Salas M; Doña I; Bogas G; Ariza A; Rodriguez-Nogales A; Plaza-Seron MC; Mayorga C; Torres MJ; Fernández TD
Allergy; 2019 Sep; 74(9):1769-1779. PubMed ID: 31034608
[TBL] [Abstract][Full Text] [Related]
8. Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory T cells.
Wang F; Wan L; Zhang C; Zheng X; Li J; Chen ZK
Immunobiology; 2009; 214(5):342-9. PubMed ID: 19362679
[TBL] [Abstract][Full Text] [Related]
9. The role of Tim-3/Galectin-9 pathway in T-cell function and prognosis of patients with human papilloma virus-associated cervical carcinoma.
Chen Z; Dong D; Zhu Y; Pang N; Ding J
FASEB J; 2021 Mar; 35(3):e21401. PubMed ID: 33559190
[TBL] [Abstract][Full Text] [Related]
10. Elevated Galectin-9 Suppresses Th1 Effector Function and Induces Apoptosis of Activated CD4
Yang S; Wang J; Chen F; Liu G; Weng Z; Chen J
Inflammation; 2017 Jun; 40(3):1062-1071. PubMed ID: 28393295
[TBL] [Abstract][Full Text] [Related]
11. [Significance of Tim-3 and Its Ligand Galectin-9 in Th1/Th2 Imbalance in Patients with Multiple Myeloma].
Zhang R; Chen S; Luo TT; Qu JH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1764-1770. PubMed ID: 38071058
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of IL-17-producing T cells is associated with regulatory T cell expansion and disease progression in chronic lymphocytic leukemia.
Jadidi-Niaragh F; Ghalamfarsa G; Memarian A; Asgarian-Omran H; Razavi SM; Sarrafnejad A; Shokri F
Tumour Biol; 2013 Apr; 34(2):929-40. PubMed ID: 23269607
[TBL] [Abstract][Full Text] [Related]
13. Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma.
Li H; Wu K; Tao K; Chen L; Zheng Q; Lu X; Liu J; Shi L; Liu C; Wang G; Zou W
Hepatology; 2012 Oct; 56(4):1342-51. PubMed ID: 22505239
[TBL] [Abstract][Full Text] [Related]
14. Galectin-9 and myeloid-derived suppressor cell as prognostic indicators for chronic lymphocytic leukemia.
Alimu X; Zhang J; Pang N; Zhang R; Chen R; Zeng X; Tudahong S; Chen G; Muhashi M; Zhao F; Ding J; Qu J
Immun Inflamm Dis; 2023 May; 11(5):e853. PubMed ID: 37249287
[TBL] [Abstract][Full Text] [Related]
15. CD4+ T Cells are Exhausted and Show Functional Defects in Chronic Lymphocytic Leukemia.
Allahmoradi E; Taghiloo S; Tehrani M; Hossein-Nattaj H; Janbabaei G; Shekarriz R; Asgarian-Omran H
Iran J Immunol; 2017 Dec; 14(4):257-269. PubMed ID: 29276179
[TBL] [Abstract][Full Text] [Related]
16. Tim-3/Galectin-9 signaling pathway is involved in the cytokine changes in mice with alveolar echinococcosis.
Li S; Zhu Y; Wang S; Li Y; Pang N; An M; Zhang F; Ding J
Mol Biol Rep; 2022 Aug; 49(8):7497-7506. PubMed ID: 35715604
[TBL] [Abstract][Full Text] [Related]
17. Blockade of PD-1 and TIM-3 immune checkpoints fails to restore the function of exhausted CD8
Rezazadeh H; Astaneh M; Tehrani M; Hossein-Nataj H; Zaboli E; Shekarriz R; Asgarian-Omran H
Immunol Res; 2020 Oct; 68(5):269-279. PubMed ID: 32710227
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive Treg cells acquire the phenotype of effector-T cells in chronic lymphocytic leukemia patients.
De Matteis S; Molinari C; Abbati G; Rossi T; Napolitano R; Ghetti M; Di Rorà AGL; Musuraca G; Lucchesi A; Rigolin GM; Cuneo A; Calistri D; Fattori PP; Bonafè M; Martinelli G
J Transl Med; 2018 Jun; 16(1):172. PubMed ID: 29925389
[TBL] [Abstract][Full Text] [Related]
19. Tim3/Gal9 interactions between T cells and monocytes result in an immunosuppressive feedback loop that inhibits Th1 responses in osteosarcoma patients.
Li X; Chen Y; Liu X; Zhang J; He X; Teng G; Yu D
Int Immunopharmacol; 2017 Mar; 44():153-159. PubMed ID: 28103502
[TBL] [Abstract][Full Text] [Related]
20. Novel Effector Phenotype of Tim-3
Liu Z; McMichael EL; Shayan G; Li J; Chen K; Srivastava R; Kane LP; Lu B; Ferris RL
Clin Cancer Res; 2018 Sep; 24(18):4529-4538. PubMed ID: 29712685
[No Abstract] [Full Text] [Related]
[Next] [New Search]